Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1436 of 5804
-
Experimental immune cell therapy targets tough leukemia
Disease control TerminatedThis is a single group, Phase 1, single-arm, dose escalation study to determine the candidate dose(s), and evaluate safety, tolerability, and preliminary anti-tumor activity of SAR445419 administered after fludarabine and cytarabine conditioning for the treatment of relapsed or r…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New imaging agent could spot hidden myeloma cells
Diagnosis Recruiting nowThis phase I trial tests the safety of \[89Zr\]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma. \[89Zr\]DFO-YS5 is an imaging agent called a radiopharmaceutical tracer. A radiopharmace…
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can a Phone-Based program help people with chronic pain cut back on opioids?
Disease control OngoingThis project aims to test simultaneously the effectiveness of telemedicine and collaborative management (TCM) vs. TCM plus Cooperative Pain Education and Self-Management (COPES) on patient level outcomes and the impact of site-tailored Implementation Facilitation to work toward l…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New blood test screening targets hidden cancer in black communities
Diagnosis OngoingThis project will pilot the expansion of the existing Taussig Outreach Program's community outreach and patient navigation model to study the multiple myeloma (MM) screening program. This involves analyzing community reception, screening program methods, reasons patients decided …
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kidney transplant patients battling BK virus
Disease control OngoingBK virus infection is one of the causes of renal allograft loss in the current era. Reduction of immunsuppression is the only intervention that prooved to be effective in treating of BK virus in kidney transplant recipient. However, there are evidences from retrospective and pros…
Phase: NA • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New program aims to cut heart risks in psoriasis patients
Prevention OngoingThe goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.
Phase: NA • Sponsor: University of Pennsylvania • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Peer support could boost opioid treatment in rural areas
Disease control Recruiting nowThe purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved are…
Phase: NA • Sponsor: University of Maryland, College Park • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can a simple dressing save lives? new trial targets ECMO infections
Disease control CompletedThe Dressing-ECMO trial is a prospective, open-label, multicenter, controlled trial randomizing patients who received percutaneous ECMO to cannula chlorhexidine-impregnated dressing vs standard dressing. The study goal is to determine if cannula chlorhexidine-impregnated dressing…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
VR meditation may help smokers kick the habit
Symptom relief Recruiting nowInvestigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving. The study hypothesis is that the practice of mindfulness me…
Phase: NA • Sponsor: Centre Hospitalier Henri Laborit • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Lung cancer drug matching: lab test could personalize treatment
Knowledge-focused Recruiting nowThis observational study evaluates if ex-vivo lung cancer drug sensitivity testing results correlate with the driver mutations found by genetic sequencing and if it can predict treatment response.
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can less be more? new study tests a gentler dosing schedule for advanced bladder cancer drug
Disease control OngoingThis is a non-randomized two arm open-label phase 2 pilot study in adult subjects with locally advanced or metastatic urothelial cancer. The study will investigate an alternative administration schedule of EV given as monotherapy and in combination with pembrolizumab.
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Implanted sensors could personalize PAH drug plans
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the capacity of implantable/remote technology for early evaluation of drug therapies in patients with pulmonary arterial hypertension (PAH). The main question it aims to answer is whether structured changes in clinical therapy will b…
Phase: PHASE4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New antibody drug shows promise for Hard-to-Treat myeloma
Disease control Recruiting nowThe study consists of three parts: Part 1 The primary purpose of this part aims to evaluate the safety, tolerability, and clinical activity of escalating doses of single agent Unconjugated belantamab antibody in participants with refractory multiple myeloma (RRMM) who have receiv…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Office-Based clot buster: new device aims to clear leg veins fast
Disease control OngoingA post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.
Sponsor: Paul J. Gagne • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Heart drug showdown: which statin spares your blood sugar?
Disease control Recruiting nowThe purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple glove trick may shield breast cancer patients from chemo nerve pain
Prevention OngoingThis study aims to demonstrate the preventive effect of compression therapy using surgical gloves in chemotherapy-induced peripheral neuropathy. Patient-reported outcome measures (PROMs) are utilized for comparing the change in neuropathic pain between intervention and control gr…
Phase: NA • Sponsor: Young-Joon Kang • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control TerminatedStudy CP-MGC018-03 is an open-label, two-part, Phase 2 study. Part 1 of the study will enroll participants with metastatic castration-resistant prostate cancer (mCRPC) previously treated with one prior androgen receptor axis-targeted therapy (ARAT). ARAT includes abiraterone, enz…
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Hip implant tracked for a decade: will it last?
Disease control CompletedThis clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in rel…
Sponsor: Societe dEtude, de Recherche et de Fabrication • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New study checks if filgotinib keeps ulcerative colitis in check Long-Term
Disease control OngoingTo describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world setting.
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a new PET scan pinpoint the cause of Cushing's syndrome?
Diagnosis Recruiting nowIn previous clinical practice, 68Ga-Pentixafor PET/CT has demonstrated promising diagnostic utility in various neuroendocrine tumors by targeting CXCR4, a chemokine receptor overexpressed in several ACTH-secreting neoplasms. Building on this, and leveraging the Nuclear Medicine e…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC